NCATS, in collaboration with other NIH Institutes and Centers and the Food and Drug Administration (FDA), is leading the Tissue Chip for Drug Screening program to develop human tissue chips that accurately model the structure and function of human organs — such as the lungs, liver and heart — to help predict drug Safety in humans more rapidly and effectively
View this resource Bookmark this resource
Tissue Chip for Drug Screening program and Consortium
Published by IRDiRC
Research and Drug DevelopmentBiomarkerDrug DiscoveryNCATSHigh Throughput ScreeningTissue ChipDrug Screening ProgrammeLibrary